eNeura
PrivateLast Round
Series D
Feb 6, 2018
Total Funding Raised
$62.38M
Company Overview
eNeura operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series D round in February 2018.
eNeura is a medical technology company that has developed a portable, non-invasive transcranial magnetic stimulation device for the treatment and prevention of migraines.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Patient Engagement, Health IoT
Business Model
B2C
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eNeura Comparables
Compare eNeura with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cefaly Technology | 84% | |
| Neurolief | 82% | |
| electroCore | 79% |
For institutional investors. Book with your work email.
eNeura Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Feb 6, 2018 | ||||
| Series C | Mar 10, 2016 | ||||
| Series B | Aug 28, 2014 | ||||
| Series A Extension | Aug 19, 2013 | ||||
| Series A | Nov 8, 2012 | ||||
VC Round | Jan 11, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
eNeura Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abell Foundation | Series D |
| Catalio Capital Management | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2025
Grew 80% QoQ from 5 to 9 employees.
- Apr 4, 2025
Grew 60% QoQ, from 5 to 8 employees.
For institutional investors. Book with your work email.
eNeura Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about eNeura's valuation, stock price, and market status.
Is eNeura a public or private company?
eNeura is a private company.
What is the current stock price of eNeura?
eNeura is a private company, so its shares have no public market price. Caplight tracks eNeura's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is eNeura worth (valuation)?
Valuation information for eNeura is not publicly available.
Can I buy eNeura stock?
eNeura shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was eNeura's last funding round?
eNeura's most recent funding round was Series D on February 6, 2018.
Who are the main investors in eNeura?
Key investors in eNeura include Catalio Capital Management.
Will eNeura IPO soon?
No public IPO plans have been announced for eNeura.
How can I track eNeura secondary market activity?
Caplight tracks bids, offers, and trades in eNeura's shares on secondary markets.